Revolution Medicines Ownership & Insider Activity

Revolution Medicines (RVMD) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 1.8% of shares outstanding. Institutional investors hold 50.0%. Over the past 90 days, insiders made 8 sales worth $33.0M.

Shares Outstanding

214.336M

Shares Float

202.974M

Insider Shares Owned

3.902M

Insider % Owned

1.8%

Institutional Shares Held

107.083M

Institutional % Held

50.0%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

Sales (90d)

$33.0M total

Net Activity

Net Selling

Net Value (90d)

-$33.0M

Revolution Medicines Insider Transactions (Last 6 Months)

Date	Insider	Title	Type	Shares	Price	Value
Aug 21, 2026	Jeff Cislini	GENERAL COUNSEL	SELL	614.000	$114.62	$10.8M
Aug 21, 2026	Mark A Goldsmith	SEE REMARKS	SELL	6.000K	$106.96	$17.6M
Jun 29, 2026	Sushil Patel	—	SELL	2.625K	$112.76	$938K
Jun 24, 2026	Jack Anders	CHIEF FINANCIAL OFFICER	SELL-OPTIONS	—	$93.45	$3.0M
Jun 16, 2026	Anthony Mancini	SEE REMARKS	SELL	4.615K	$156.12	$720K
Jun 16, 2026	Mark A Goldsmith	SEE REMARKS	SELL	10.020K	$156.12	$1.6M
Jun 16, 2026	Jeff Cislini	GENERAL COUNSEL	SELL	2.157K	$156.12	$337K
Jun 16, 2026	Jack Anders	CHIEF FINANCIAL OFFICER	SELL	2.722K	$156.12	$425K
Jun 16, 2026	Stephen Michael Kelsey	SEE REMARKS	SELL	4.175K	$156.12	$652K
Jun 11, 2026	Margaret Horn	CHIEF OPERATING OFFICER	SELL-OPTIONS	—	$94.47	$1.1M
May 26, 2026	Anthony Mancini	SEE REMARKS	SELL-OPTIONS	—	$93.81	$376K
Apr 27, 2026	Anthony Mancini	SEE REMARKS	SELL-OPTIONS	—	$83.02	$308K
Apr 15, 2026	Mark A Goldsmith	SEE REMARKS	SELL-OPTIONS	—	$77.35	$17.5M
Mar 25, 2026	Anthony Mancini	SEE REMARKS	SELL-OPTIONS	—	$64.59	$2.3M
Mar 17, 2026	Wei Lin	CHIEF MEDICAL OFFICER	SELL	2.073K	$99.48	$206K
Mar 17, 2026	Stephen Michael Kelsey	SEE REMARKS	SELL	4.302K	$99.48	$428K
Mar 17, 2026	Mark A Goldsmith	SEE REMARKS	SELL	12.871K	$99.48	$1.3M
Mar 17, 2026	Margaret Horn	CHIEF OPERATING OFFICER	SELL	4.583K	$99.48	$456K
Mar 17, 2026	Jack Anders	CHIEF FINANCIAL OFFICER	SELL	2.753K	$99.48	$274K
Mar 17, 2026	Jeff Cislini	GENERAL COUNSEL	SELL	2.958K	$98.68	$292K
Mar 17, 2026	Xiaolin Wang	SEE REMARKS	SELL	2.010K	$99.48	$200K
Mar 1, 2026	Mark A Goldsmith	SEE REMARKS	SELL-OPTIONS	51.100K	$52.66	$3.5M